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INTRODUCTION

Endoscopic percutaneous endoscopic gastrostomy
(PEG) tube removal is a commonly performed procedure
with known complications associated with mechanical
trauma from removal of the mushroom catheter (see
Figure 1). Mechanical trauma presents with
gastrointestinal bleeding which can lead to severe
complications if aspirated into the oral cavity or if left
uncontrolled. This normally warrants a repeat
esophagogastroduodenoscopy (EGD) to stop the
bleeding.
Given our current COVID-19 pandemic, there is an
increasing need to test patients for COVID-19 prior to
getting any out-patient procedure. As the most common
method for COVID-19 testing is a nasopharyngeal swab
(see Figure 2), epistaxis should be an increasingly
expected complication due to minor trauma of the nasal
mucosa. This bleeding can often be mistaken for a
complication of the out-patient procedure and therefore
should be screened prior to initiating the procedure. Here
we discuss a case of epistaxis post-endoscopic PEGtube removal secondary to COVID-19 testing
nasopharyngeal swab.
CASE
SUMMARY

The patient was a 64-year-old African American male
who underwent an EGD for PEG tube removal. Patient
stated that he currently takes Clopidogrel and did not
hold his Clopidogrel prior to the EGD. The procedure was
performed by a gastroenterologist (with more than 30
years of endoscopy experience). Patient was properly
anesthetized with propofol by a CRNA. A snare was
placed around the mushroom of the stomach portion of
the PEG tube. The outer portion of the PEG tube was cut,
and the mushroom was removed with the endoscope.
Post-EGD, while the patient was still anesthetized, the
patient started choking on his own blood. Upon
suctioning, several blood clots were removed from the
patient’s mouth. A repeat EGD was performed by the
same gastroenterologist, which confirmed no active
bleeding in the esophagus or stomach. After the repeat
EGD, the patient begins to wake up and informs that he
has been having nose bleeds for the past three days
following his COVID-19 nasopharyngeal swab. Patient
was sent to the emergency department for further
evaluation.

DISCUSSION

Percutaneous endoscopic gastrostomy (PEG) tube is commonly placed following a cerebrovascular
accident when the patient has persistent neurological dysphagia (1). Once the patient regains
spontaneous swallowing, the PEG tube can be removed (1). There two main ways in which the PEG
tube can be removed, the “cut and push” technique or the endoscopic removal (1). The “cut and
push” technique is where the PEG tube is cut as close to the skin as possible. The external part is
removed, and the internal bumper is allowed to pass through the bowel and excreted rectally (see
Figure 1) (2). The “cut and push” technique can lead to a PEG ileus, where the internal bumper gets
lodged in the small bowel creating a small bowel obstruction. As a result, it is recommended to the
remove PEG tubes endoscopically (3). Endoscopic removal of a PEG tube involves pulling the
internal bumper up with the endoscope and out of the oral cavity. Although uncommon, this can
cause trauma to the stomach and esophagus as the mucosa is traumatized by the internal bumper
scraping across. In this patient it was decided that his PEG tube be removed endoscopically to avoid
the risk of creating a PEG ileus if the “cut and push” technique was used.
Clopidogrel is an oral irreversible P2Y12 receptor antagonist which is widely used to prevent future
thrombotic events (4). Like all other antiplatelet drugs, clopidogrel does increase the risk of bleeding
(5). Unlike most other antiplatelet drugs however, it is not recommended stopping Clopidogrel prior to
performing EGD or PEG-tube insertion/removal as the risk of hemorrhage is considered low (5). As a
result, the patient continuing his Clopidogrel was not a reason to cancel the endoscopic PEG-tube
removal. Instead, more caution was used to ensure no uncontrolled bleeding developed as a result
of his antiplatelet therapy.
Given the current coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, there is an
increasing need to test patients for COVID-19 prior to getting out-patient procedures such as PEG
tube removal. The most frequently used test for detecting SARS-CoV-2 is a nasopharyngeal swab
(see Figure 2) followed by a reverse transcriptase-polymerase chain reaction (RT-PCR) to identify
viral RNA (6). Although not highly prevalent, the most common complication of a nasopharyngeal
swab is epistaxis (7). This is because the nasal mucosa is highly vascularized which makes it prone
to bleeding from mild trauma.

Figure 1. A drawing of a PEG-tube
placed in a patient. (8)

Figure 2. A depiction of a nasopharyngeal swab being
performed for detecting SARS-CoV-2. (9)

CONCLUSION

Patient was examined in the emergency department
where his nose was packed with gauze to stop the
bleeding. He was then discharged home shortly after as
his bleeding was controlled.
Learning Points:
 Endoscopic PEG-tube removal can result in
complications related to uncontrolled bleeding.
 Patients on blood thinners are at an increased risk of
bleeding complications from procedures.
 With the increase in nasopharyngeal COVID-19
testing swabs, patients should be screened for
epistaxis prior to out-patient procedures as this can
obscure procedure-related complications.
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